Home › Type 2 Diabetes › Missouri › Kansas City

Pag-aaral pangklinika para sa Type 2 Diabetes sa Kansas City, MO

Isang pag-aaral para sa Type 2 Diabetes ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Kansas City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Nagre-recruitPhase 3

Alliance for Multispecialty Research - Kansas City, Kansas City

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07684144

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Nagre-recruitPhase 3

Johnson County ClinTrials, Kansas City

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07064473

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Nagre-recruitPhase 3

Research Site, Kansas City

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07776509

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Nagre-recruitPhase 3

Research Site, Kansas City
Research Site, Kansas City

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07784270

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Nagre-recruitPhase 3

Kansas City VA Medical Center, Kansas City

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07351058

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Nagre-recruitPhase 2

Clinical Research Consultants, LLC, Kansas City

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07271186

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Nagre-recruitPhase 3

Research Site, Kansas City

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07662213

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

Nagre-recruitPhase 3

Research Site, Kansas City

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07662135

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Nagre-recruitPhase 3

Johnson County ClinTrials, Kansas City

Edad 45 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

Nagre-recruitPhase 3

Research Site, Kansas City

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT07662044

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Nagre-recruitPhase 2

Clay Platte Family Medicine, Kansas City

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07527650

Pag-aaral para sa Type 2 Diabetes sa ibang lungsod

Iba pang pag-aaral sa Kansas City

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.